Sphingosine-1-phosphate receptors: Biology and therapeutic potential in kidney disease

74Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The major sphingolipid metabolite, sphingosine-1-phosphate (S1P), has important biological functions. S1P is the ligand for a family of five G-protein-coupled receptors with distinct signaling pathways that regulate angiogenesis, vascular maturation, immunity, chemotaxis, and other important biological pathways. Recently, clinical trials have targeted S1P receptors (S1PRs) for autoimmune diseases and transplantation and have generated considerable interest in developing additional, more selective compounds. This review summarizes current knowledge on the biology of S1P and S1PRs that forms the basis for future drug development and the treatment of kidney disease. © 2008 International Society of Nephrology.

Cite

CITATION STYLE

APA

Jo, S. K., Bajwa, A., Awad, A. S., Lynch, K. R., & Okusa, M. D. (2008). Sphingosine-1-phosphate receptors: Biology and therapeutic potential in kidney disease. Kidney International. Nature Publishing Group. https://doi.org/10.1038/ki.2008.34

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free